Citius Oncology

CTORNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$70.015 M

$0.75 -0.92%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

-$24.8M

Loss-making

Shares outstanding

92,981,204

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#329CingulateCING$71.9M
#330iBioIBIO$70.0M
#331Citius OncologyCTOR$70.0M
#332Rein TherapeuticsRNTX$69.9M
#333XBiotechXBIT$69.2M

Where these numbers come from

Share counts and financials for Citius Oncology are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.